High levels of pathogen resistance are rendering current antibiotics
obsolete. Coupled with insufficient investment in discovering new
treatments, multidrug-resistant infections are an increasingly urgent
public health concern.
To curb the growth of antibiotic resistance and prevent major morbidity
and mortality from multidrug-resistant bacterial infections, the overuse
of antibiotics must be addressed and research and development for
antibiotics with novel mechanisms of action actively promoted. This
requires appropriately designed incentives for health and regulatory
systems, in addition to economic incentives to attract academic interest
and industry investment.
This book, commissioned by the Swedish Government from the European
Observatory on Health Systems and Policies, analyzes many proposed
policies and incentive mechanisms and sheds light on the key issues that
will help policy-makers reach informed, concrete decisions on how to
avert this potential public health crisis.